CD274 and neoplasm: In addition, the added PD-L1 antibodies effectively reversed NK cell activity by releasing PD-1 from the PD-L1–PD-1 complex; these antibodies also effectively reversed the expression of NKG2D ligand on tumor cells, which further enhanced the killing ability of NK cells against tumor cells (63).